Inhibition of human cholinesterases by drugs used to treat Alzheimer disease.
about
Melatonin metabolism in the central nervous system.Methamidophos, dichlorvos, O-methoate and diazinon pesticides used in Turkey make a covalent bond with butyrylcholinesterase detected by mass spectrometryBACE1 inhibitory activity of fungal endophytic extracts from Malaysian medicinal plantsDichlorvos, chlorpyrifos oxon and Aldicarb adducts of butyrylcholinesterase, detected by mass spectrometry in human plasma following deliberate overdose.Differential effects of acetylcholinesterase inhibitors on clinical responses and cerebral blood flow changes in patients with Alzheimer's disease: a 12-month, randomized, and open-label trialSynergistic inhibition of butyrylcholinesterase by galantamine and citalopram.Rivastigmine: a placebo controlled trial of twice daily and three times daily regimens in patients with Alzheimer's disease.Assessment of Anticholinesterase Activity of Gelidiella acerosa: Implications for Its Therapeutic Potential against Alzheimer's DiseasePharmacological management of anticholinergic delirium - theory, evidence and practiceInteraction of human brain acetylcholinesterase with cyclophosphamide: a molecular modeling and docking studyElucidation of Molecular Mechanism(s) of Cognition Enhancing Activity of Bacomind®: A Standardized Extract of Bacopa Monnieri.Once-daily transdermal rivastigmine in the treatment of Alzheimer's disease.Rivastigmine transdermal patch: a review of its use in the management of dementia of the Alzheimer's type.Rivastigmine transdermal patch 13.3 mg/24 h: a review of its use in the management of mild to moderate Alzheimer's dementia.The kynurenine pathway and the brain: Challenges, controversies and promises.Mechanistic comparison of current pharmacological treatments and novel phytochemicals to target amyloid peptides in Alzheimer's and neurodegenerative diseases.Acetylcholinesterase inhibitors ameliorate behavioral deficits in the Tg2576 mouse model of Alzheimer's diseaseA preliminary investigation of anticholinesterase activity of some Iranian medicinal plants commonly used in traditional medicine.Cocaine cardiovascular effects and pharmacokinetics after treatment with the acetylcholinesterase inhibitor donepezil.Cysteine thioesters as myelin proteolipid protein analogues to examine the role of butyrylcholinesterase in myelin decompaction.Probing the peripheral site of human butyrylcholinesterasePlasma-Enabled Carbon Nanostructures for Early Diagnosis of Neurodegenerative Diseases.Thioesters for the in vitro evaluation of agents to image brain cholinesterases.Buccoadhesive films for once-a-day administration of rivastigmine: systematic formulation development and pharmacokinetic evaluation.Butyrylcholinesterase identification in a phenylvalerate esterase-enriched fraction sensitive to low mipafox concentrations in chicken brain.Kinetic analysis of effector modulation of butyrylcholinesterase-catalysed hydrolysis of acetanilides and homologous esters.Anti-inflammatory effects of ladostigil and its metabolites in aged rat brain and in microglial cells.Micropropagation of Ficus religiosa L. via leaf explants and comparative evaluation of acetylcholinesterase inhibitory activity in the micropropagated and conventionally grown plants.Pharmacokinetics and pharmacodynamics of the novel daily rivastigmine transdermal patch compared with twice-daily capsules in Alzheimer's disease patients.
P2860
Q30476606-2E33B4CE-C92B-4C18-A9A4-6457231BD8F8Q33540734-73951DCF-C0E8-436C-9E41-C6A584EA9E1CQ34029099-3F2611C0-D925-48C4-886D-6685BAC6FA81Q34116714-FD56E027-5EA4-46AF-A9D6-E0F0EEE007BEQ35631407-18C55D00-58AA-4CE9-8F89-811019DA98D2Q35687175-EC182F4B-DF3C-492C-816C-DBF60201C05EQ36226630-19F86D15-697E-4014-9474-6C126FB7E689Q36475062-1207D567-3AE6-48D5-B591-8C1DED12F516Q36618115-EA9F32E7-F82E-4DF0-8C89-DC567F911CDAQ37161493-F0245DEF-D7A4-45E5-B46D-B5E27906B856Q37346425-0D027B39-DD6A-4697-A4F1-02AABF5EBB92Q37385577-63F9B134-4F93-46E3-B11B-88A1D5BEC88AQ37895257-99773B2B-9554-4369-8C64-0395078E1B26Q38225721-EA48D182-C21D-4F1D-B8A9-823EF29D7043Q38832497-747BD472-02FA-48EF-BA31-D80B43D73F81Q39418685-627392B2-B80C-4950-B40D-EB9822B680ABQ41849847-B1B33A29-78FC-49F6-A697-D65601D1830FQ41880802-91EDCB0F-A963-4C38-8257-CFBC690CC928Q41944787-0BC37216-8E16-4DC4-AA30-20EF99363B53Q42127860-4B9B4772-9075-488E-85FB-505328C17903Q42144416-4DFB56A2-3F6D-4DE6-84D0-81E387804410Q42227546-B6688200-C2C4-4B1F-98CF-6338A3F7011CQ44322285-4D1950EF-AA72-48A8-8709-00C5F90B7E15Q45892584-169EF8C9-3518-45F0-99C9-66E12A469BFAQ46218562-FF42E150-8282-41EE-8C86-92B02BF29055Q46636487-E2663F56-D426-4546-8CDD-A6CC6626A3B7Q48594845-449E11C2-C741-4599-9ACD-0965EF65B352Q51763299-B9CC557B-347B-4F9F-81A7-DCE9B790B377Q53386775-74E533F3-EDF1-45BE-82D5-EF205C2E7EFB
P2860
Inhibition of human cholinesterases by drugs used to treat Alzheimer disease.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh
2003年學術文章
@zh-hant
name
Inhibition of human cholinesterases by drugs used to treat Alzheimer disease.
@en
Inhibition of human cholinesterases by drugs used to treat Alzheimer disease.
@nl
type
label
Inhibition of human cholinesterases by drugs used to treat Alzheimer disease.
@en
Inhibition of human cholinesterases by drugs used to treat Alzheimer disease.
@nl
prefLabel
Inhibition of human cholinesterases by drugs used to treat Alzheimer disease.
@en
Inhibition of human cholinesterases by drugs used to treat Alzheimer disease.
@nl
P2093
P1476
Inhibition of human cholinesterases by drugs used to treat Alzheimer disease.
@en
P2093
Angela Caines
Earl Martin
Kenneth Rockwood
Rohit Kumar
Ryan Walsh
Sheila Roberts
Sultan Darvesh
P304
P356
10.1097/00002093-200304000-00011
P407
P50
P577
2003-04-01T00:00:00Z